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INTRODUCTION
Few syndromes in medicine have as bizarre and
often as catastrophic features as Granulocytopenia.
Confined to no sex or age group, it hi t.s rich ·and
poor alike. Known for only a short time, it assumes
increasing importance as medicine enters its chemotherapeutic age. Even now, forty years after the first
recorded observations on the disease, there is considerable confusion regarding it. Some investigators
feel that they deal with a group of diseases rather
than a single disease entity. This paper, arranged in
more or less text book fashion, represents a review
of the established observations with particular emphasis on the later literature and the relation of the
syndrome to the drugs of the para-amino-benzene-sulfonamide series.

DEFINITION
Granulocytopenia is a disturbance of the hematopoietic system caused by various known and unknown
factors. It is a syndrome rather than a disease and
is characterized by an acute febrile course with high
mortality, ulcerative lesions of the mucus membranes,
particularly in the oral cavity, and a striking leukopenia, in which there is a complete or almost complete
absence of cells of the gr8.nulocytic variety. 'l'he bone
marrow may be normal, hypoplastic or hyperplastic.

HISTORY
Blood counts have been made 1n large hospitals
for the past fifty years. Never the less, the disease
was

reported with such extreme rarity prior to 1922

that we usually date it from the observations of

Sc~1ltz

in tnat year.
Pepper (65), in his history of malignant heutropenia, stated that

th~

disease was mentioned in laryngo-

logic works of sixty years ago as "putrid sore throat",
and "gangrenous angina", and he said that Mackenzie,
ln his manual of diseases of the nose and throat, credited Gubler, in 1857 and Trousseau, in I865 with having
distinguished the disease from diptheria. The first case
reported in this ccuntry was that of Brown (9) in I902.
This was reported as acute primary, infectious pharyngitis with extreme leukopenia and terminated fatally.
Turck (88) reported one case in I907. Leale (53) in I9IO,
reported a case in a male child two and one half years
old under the title "Recurrent Furunculosis in an Infant Showing an Unusual Blood Picture."
Baldridge and Needles (62), In I9IO, reported a
case and pointed out that in former years it was either
overlooked because the blood was not examined or was
interpreted as a symptom of bone marrow Ohaustion,
apla.stic anemia, or a.leukemic leukemia.
Schultz(84) in I922 described fully four cases
in middle aged women characterized by severe leukopenia,
a decrease or absence of granular cells in the blood,

gangrenous throat lesions and a rapid, septic course
with death in from two to seven days. He noted the
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normal red count, the frequent jaundice, the paucity
of myeloid cells found in the bone marrow at autopsy.
Since this description many similar cases have been
reported, particularly from Germany and Ameri.ca. Many
of the cases have departed in one or more particulars from
this "Schultz" type. Uur concept of the? condition has
changed gradually as it has become apparent that a large
number of bacterial, toxic, chemical and physical agents
can produce a very similar picture. The group of cases
designated "idiopathic" is becoming steadily smaller
as definite etiological agents are discovered.

NOMENCLATURE
Since the description of Werner Schultz in I922,
many attempts to standardize the nomenclature have been
made. Schultz proposed the term

11

Agranulocytosis". This

term, while brief, is ambiguous. By ''agranulocytes n are
meant those neutrophiles without granulations which are
seen in blood smears from cases of leukemia. The term
"Agranulocytosis" suggests an increase in these atypical
neutrophiles, quite the opposite from the impression
desired.
The name '1Agranulocytic Angina", perhaps in greater
use th"oi.ll any other, was proposed by Friedemann (28) who
was impressed by the usual localization of lesions in
the throat. This term has the same intrinsic ambiguity
regarding the granulocytf:s as the first one mentioned
and is doubly undesirable in the light of later day

-4knowledge that cases do exist without a.ngina.
Schilling (82), suggested the term "malignant
Neutropenia" which contains no ambiguities but does
not recognize that there are also benign and recurrent
forms.
Rosenthall (76) in his classification divided
neutropenia into malignant (fatal) and benign (recovr:ired) cases.
Many other terms have been suggested, such as
agranulosis, mucositis necroticans agranulocytica,
monocytic angina, sepsis with granulopenia, idiopathic
neutropenia and pernicious leukopenia.
Beck (4) has suggested a rather adequate classification into I. primary benign and primary malignant neutropenia in which the etiology is unknown;
2. secondary benign and secondary malignant neutropenia,
the cases in which the etiologic agents are evident
or in which one is dealing with well recognized clinical
entities.
For a simple term covering the syndrome in a
general way I should like to propose the name "Granulocytopenia". This is a trifle more descriptive than
the term ttNeutropenia" and conveys the idea that there
is a shortage of cells of the granulocytic series.
ETIOLOGY
During the short time that we have recognized the
syndrome of granulocytopenia our conception of it has
changed tremenduosly. Werner Schultz advanced no theory
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as to the cause of it. He remarked that it seemed to
occur in women and was invariably fatal. (Since that
time numerous cases have occured in males and numerous
cases have recovered.)
Hueper (33) found a. ratio of three and one half
women to one man, or 77.5 'ftc in women. Roberts and Kracke
(7'6) presented a table compiled from 8,000 leukocyte
and differential counts which showed this trend in
chronic cases (56

~being

in females). The majority of

cases seem to occur in the fourth decade of life.
Cases have occured i.n children, in young adults and
in very old people, but these are more rare. The two
countries which seem to have the greatest incidence
are Germany and the United States.
Gordon (29) in his article on the etiology and
treatment of granulocytopenia has given a classification
factors
of the various which have at one time or another been
incriminated in the production of the syndrome.
A. Unknown- the malignant neutropenia of Schultz.
·B. Chemicals and drugs - benzol, hydrocarbon, trinitre-toluene, arsenobenzol, bismuth, bismarsen, amidepyrine, barbital, dinitrophenone etc.
c. Bacteria - streptococci of all types, staphylococci ( aureus and albus), Vincents' spirillum and the
fusiform bacillus, pneumococcus, gram negative and
gram pbsitive cocci, gram negative and gram positive
bacilli, bacillus coli, bacillus pyocyaneus, bacillus
subtilis, bacillus dipth'::!riae, the meningococcus and
the gas gangrene bacillus.
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D. Malignant neutropenia has developed in people
under treatment for; cholecystitis, cardiac disease,
arthritis, amebic and ulcerative colitis, furuncu1osis,
syphilis, tuberculosis and cancer.
E • .Allergy, particularly asthma, has been reported
to be one of the causes of malignant neutropenia.
F. A congenital condition of the bone marrow has
been demonstrated and a maturation arrest described
by some authorities as a cause.
G. ?iologically, it has followed the use of prophylactic typhoid serum and diptheria anti-toxin.

H. Physically it has followed the use of x-ray
therapy. Extraction of teeth and fractures of bone
have been described as etiological factors.
I. The menses and pregnancy have been described
as etiological factors •.
(Gordon does not feed that drugs are the predominant etiological factor. In his series of 59 cases
only one had taken medicines of the benzene series. This
view is concurred in by T.H. Boughten of Akron, Ohio,
who states that in the rubber factories where benzene
is in general use among the workers he has seen a great
many cases of benzene poisoning, yet in spite of constant watchfulness has seen only two cases of agranulocytosis, neither of the workers having been exposed

to

any form of industrial poisoning.) (54)
On the opposite side of the fence may be b alanced
the clHssic work of Kracke and his associates, (41-46)
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(63) who in 1934 declared flatfootedly that "acute
fulminant granulopenia and other types as well are
caused for the most part by

th~

administration of

easily oxidizable benzene ring drugs? I" Others of
their conc1usions were: not the benzene nucleus itself, but an axidizable end product of it (quinone
or catechol) is at fault. This was proven by injecting rabbits with benzene, inducing granulopenia and
recovering catechol from the bone marrow. They also
oxidized amidopyrine and phenacetine, two of the drugs
more commonly associated with granulocytopenia, and
proved by chemical reactions and spectrum analysis
that one ofthe end products was quinone.
In an analysis of 1314 cases, four drugs were
incriminated by Kracke and associates: gold salts,
arsphenamine, amidopyrine and phenacetin. It was
pointed out that these all have certain structures
in common, the benzene grouping with an attached
amino radical. Straight chain barbiturates they did
not incriminate but those with the benzene nucleus
were found to be associated with the syndrome.
Kracke and associates also pointed out the
quite interesting and significant fact that physicians,
nurses, pharmacists and those in eontact with benzene
drugs have a far greater incidence as a class.
In an address delivered before the 1940 meeting
of the Omaha Midwest Clinical Society, Dr. Kracke
listed several other drugs which have been found at
times to be associated with the syndrome.These include
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dinitrophenol, used to reduce weight, gold salts, used
in arthritis, organic arsenical compounds, used in
syphilis therapy, and the sulfanila.mide derivatives.
The flaw, of course, in the theory of the causation
of the syndrome by drugs alone is that their action
can not be predicted and it is impossible to effect a
reduction of the human white count by experiment«.:.l
giving of the drugs. Apparently some peculiar set of
circumstances must be present in the body economy 'ere
the neutropenic state can be induced by the coal tar
products and others. Parker and Kra.<"!ke (63) have recently suggested 'that the reduced form of glutathione
plays an important part in the regulation of bone marrow
activity. They find this substance to be markedly reduced in the bone marrow and blood of animals in which
granulocytopenia has been produced by benzene.
Farley (20) reviewed from the literature thirty
nine cases in which the function of the bone marrow
was depressed_following the use of various preparations
of arsphenamine. The symptoms varied from those of pur-

"''

pura hemorrhagica to those of severe aplastic anemia and
malignant neutropenia, depending on whether the prine!iple effect was on the granulopoietic, megakaryopoietic
or erythroblastic tissues, or on all of these combined.
Madison and Squier were the first to incriminate
amidopyrine, especially in combination with a barbiturate,
as a cause of granulocytopenia. They found that the
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onset of granulopenia was often directly preceded by
the use of amidopyrine alone. Several oftheir patients
were known to have a normal blood count and even a
leukocytosis before the use of the drug.
Imerman and Imerman (34) in 1936 reported 8 cases
of granulocytopenia developing from the use of dinitrophenol to r8duce

w~ight.

All eight patients

~ere

women

and their ages ranged from I8 to 48 years. The drug was
used within apparently normal limits in every case.
The most important pro-dromal symptoms occurred from
ten days to four months after the drug was started and
consisted of fever, sore throat and headache. Five of.
the patients recovered (the five who received peritnucleotide therapy). The other patients, treated with
adenine sulfate, liver extract and blood transfusions
died.
Many other drugs have been mentioned, a

fe~,v

of

which are antipyrine, acetanilid, atophan, phenacetin,
novaldin, nirvanol, quinine, plasmochin and neostibosan.
Amidopyrine, however, remains the chief of'fender and
no more Bloquent testimony can be given than the amazing decrease in the incidence of the di:3ease not only
in Denmark but also in the United States since the .danger ofthe drug has b een popularized. That amidopyrine
is not the whole story is shown by incidents in

whi~h

patients known to be suf f8ring from granulocytopenia
were given amidopyrine as- a sedative with complete
recovery following. (71)

-IOIn approximately one third of the cases of granulocytop0nia, the blood culture is positive for some
organism. This usually represents secondary infection,
hmvever, resulting from the depressed white count.
'T'he concept has been held by numerous authors th<,.t
granulocytopenia is an infectious disease. (I5, 2I, 90,
93). Attempts to induce the disea:-3e by introducing into
animals organisms isolated from lesions, hone marrow
and blood stream of patients have failed to give any
conclusive informe.tfon. A large number of patients
give a history of Vincent's angina prior to the

clini~al

onset. This may well be the result of an unrecognized
granulocytopenia of a chronic nature.
Fried and Dameshek (27) induced neutropenia experimentally by innoculating the blood stream of rabbits
with the organism Salmonella Buipestifer. By grading the

size of the dose they were able to produce two types
of cases, those in

whi~h

the animal recovered and ful-

minating cases ending fatally. The blood picture showed
leukopenia and neutropenia but not a clear cut granulocytopenic picture.
Piersol and Steinfield (66) found that a long
continued granulopenia conld not be induced in healthy
rabbits by the use of a small group of common bacteria.
A distinction should probably be made between
marked secondary leukopenia and neutropenia due to an
infection, and primary neutropenia in which the primary

-IIlesion is in the blood or bone marrow and the organisms
growing in a system devoid of granulocytes. If this
distinction be kep:t in mind it would seem that it is
attacking the etiology from the wrong standpoint to
attempt to exhaust the bone marrow by the introduction
of organisms.
In Dennis' experiments (I6), various organisms
derived from neutropenic patients were placed in parchment capsules and within the peritoneal cavity of animals to produce the condition. The animals having the
most suggestive results showed on post-mortem examination , pneumcmcti, whi::!h were not among the bacteria
tested.
Some very interesting work, the results of which
have not yet been published, has been done by Lawrence
(52) and his associates. They have produced in cats a
disease similar to the hum.an disorder and labelled
"Infectious Feline Agranulocytosis". This has been shown
to be due to a filterable virus and shows pronounced
granulocytopenia on the sixth to ninth day after exposure. Inthe bone marrow there is invariably absence
of differentiation into late myeloid forms at the
height of the disease. The mechanism in both the human
a.nd the feline forms they feel may be due to peripheral
destruction. The very sudden disappearance of neutrophiles
following amidopyrine would suggest this. In the eat
a transfusion with one third a body volume of blood
from another cat with the same quantity removed from
the stricken animal by cardiac p1mcture was unable to
elevate tile white count and the granulocyte count- also
suggesting peripheral destruction.

-I2This theory that a fil t·;rable virus m<;_y be the cau3e
of the

granulocytop,~nic

syndrome is extremely inter-

esting and entirely plausible but would seem to await
much more confirmation. Zikciwski (94) in I93I ::;hared thL:
view suggesting that a virus having a special affinity
for granulopoietic tissue might induce a severe form
of sepsis in the weakened organism, injuring not only
the granulopoietic system but paralyzing the organ complex (liver, spleen and e"docrine glands) which stimulate the bone marrow and govern the release of white
cells into the blood stream.
A few authors believe that granulocytopenia may
be a form of allergy in which the bone marrow is the
area afflicted. Schilling (82), a name to be conjured
with in blood picture interpretation, has this viewpoint. He was able to experimentally produce a blood
picture similar to granulocytopenia by inducing anaphylaxis. Bromberg and Murphy (6I) reported a case
following prophylactic typhoid vaccination. Kraoke
reported a case and said; "The question of typhoid
prophylaxis as a whole or partial cause of the condition must be considered." Meyer reported a case
following malarial therapy. Those cases showing eosinophilia during an attack suggest i:i.naphylaxis.
A rather interesting parallel is drawn by R.C.
Beck (4) between granulocytopenia and pernicious
anemia. Granulocytopenia in its recurrent phase is

-I3somewhat similar in its clinical cour3e to pernicious anemia.
Cr:;.stle called attention to the intrinsic and
extrinsic factors which are missing in pernicious
anemia, and Beck postulates a

chf~motactic

and mat-

uration factor which may be mis '>ing in granulocytopenia. The marked therapeutic action of pentnucleotide extract may be due to these factors contained
in it.
This concept is supported by the fact that there
can be marked myeloid hyperplasia accompanying the
neutropenia - in fact there can be any type of myeloid tissue. Beck's theory presupposes a chemotactic

substance present in the broken down products of white
cells (nucleic acid and its degradation products) which
stimulates the bone marrow to myeloid activity. Thus
stimulated, a maturation factor

al~rn

present in the

bone marrow comes into play. In a normal or hyperpl&stic bone marrow this second, maturation factor
is assumed to be missing.
There is good evidence that diet may play a prominent part in the production of the; syndrome. Miller
and Rhoads (59) developed an ulcerative stomatitis in
dogs by means of a diet causing blacktongue (Goldberger' s diet). The terminal features of the illness vVere;
I. Ulcerative, gangrenous stomatitis with spiral and
fusiform

organism~
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2. Leukopenia, granulopenia and a suppressio11. of the
hematopo1etic elements of the bone marrow.
Lillie demonstrated lesions of the myelin sheaths
of the nerves lea.ding to the ulcerated areas - hence
assuming the mucus

membr&nr~

change to be trophic in

nature. Total absence of granulocytes was

nE:~ver

ohs-

erved !
The bone marro·N changes 'Nere: I. A di la ta tiun of
capillaries. 2. A cessation of maturation of hematopoietic cells. These are the identical changes produced by the administratlon of certain toxic, aromatic
compounds of the benzene series.
The re la ti on between IDfms trua ti on and th•2 agranulo-

cytic syndrome has been often noted. W.P. Thompsen (87)
found that in 17 out of 18 young women vl/i th granulocy:topenia, symptoms began within a day or two of menstruation.
All were menstruating upoh hospital admission. One or
more recurrences were observed in six of these - each
with the onset of ca.tamenia. Two young women with previous attacks of granulocytopenia were followed through
a menstrual period. In both a distinct but transient
neutropenia developed with symptoms just before catamenia. The excretion of female sex and gonadotropic:
hormones was followed through the neutropenic phase of
a well known male case of cyclic granulocytopenia. The
results suggest that neutropenia occurs, in this young
man, at the time of hormonal catamenia. (This patient
developed within two years a diabetes insipidus - also
interesting is the fact that they Nere able to abort

-I5a scheduled attack with pentnucleotide extract. In this
patient the fall in granulocytes definitely precedes
the fever, buccal necrosis and other symptoms.)
A familial tendency to granulocutop:mia is a
possibility. Hart (32) suggested this having observed
the syndrome in two sisters. Wolf (SI) reported granulocytopenia as reactions to the 3ame infection in
brother and sister. Congenital granulopoietic insufficiency seems to exist in some cases but the granulopoietic tissue in most of the familial linked cases
seems to have functioned normally for many years.
Blumer dismissed the possibility of a congenital
anomaly with this statem;nt; "The same patient has
reacted with the usual leukocytosis and granulocytosis to one attack of an infection and has shown a
leukopenic and neutropenic reaction to another attackl"
The possibility of a constitutionally limited bone
marrow would seem as yet a theoretical 1uestion.
PATHOLOGY
The absence of white cells of the granulocytic
series accounts for the high incidence of blood
cultures, the anginal lesions and the peculiar form
of inflammation which accompanies both benign and malignant granulocytopenia. Tissue ulceration and necrosis
lack the exudative features of the normal reaction
ac companied by polymorphonuclear leukocytic infiltration. Lymphocytes may be present, also macrophage
cells and endothelial cells. Infection spreads like
wildfire due to the lack of development of an inflammatory barrier. Any site in the body where bacteria

-I6normally flourish may become the site of focal infection.
This is particfilarly true of the

g~stro-intestinal

tract.

Ordinary inhabitants of this system me.y gain the ascendency to become pathogenic.
'Pone marrow infection may oc::!ur. Muller in his series
of cases of influenza found that the red marrow had been
invaded by organisms and

damag(~d

e.nough to interfere

with granulopoiesis. The yellow marro·N was not damaged
and there was evidence to show that it had taken over
some of the function of th''' red marr·ov1r. The hone marrow
has never been shown to be infected in granulocytopenia
save in the terminal stages of a septicemia but it would
seem logical that this could occur - particularly in a
fulminating case with an absence of granulocytes.
In f a.tal cases of granulocytopenia the bone marrow
is degenerated to a very great extent. It varies in color
from red to straw and may be liquified. Areas of patchy
necrosis may be seen. The myelocytes and polymorphonuclear cells are absent or nearly so. Normoblasts and
megakaryocytes are present in their normal numhers.
With the maintenance of the gross, fatty structure,
granulocytes may be ab3ent or nearly so but erythrocy.tes, lymphocytes and endothelial

leuko~ytes

may be

present. Generally the bone marrow is in a state of
myeloid hypoplasia or aplasia. It may be normal as
to myeloid elements and cases have beo:m reported with
a myeloid hyperplasia.

-I7The condition of the spleen largelJ hinges on
the septic or toxic

proces:~es

that occur. Enlargement

of the spleen, seen in some cases, is due to a tremenduous increase in the reticulo-endothelial cells which
outnumber the lymphoid cells. The splenic '>inu';es are
filled with erythrocytes, reticulo-endothelial cells
and lymphoid cells. Small anemic infarcts are occasionally seen.
The lymph follicles are small and

atrophic~

and

there are no lymphoblasts or young.cells in the germinal centers, only mature lymphocytes. The cervical,
sub-maxillary, peribronchial and mesenteric groups
are frequently enlarged and may contain hemorrhages.
The liver is often enlarged and may show cloudy
swelling. There is an increase in Kupffer's cells,
bile pigment in the hepatic cells.and bile casts in
the capillaries. Sometimes there are interstitial
lymphocytic infiltrations and there may be small,
multiple foci of necrosis.
The lungs are· frequently the site of a pneumonic:
process. The gross picture is similar to influenzal
pneumonia. There is diffuse edema of a hemorrhagic
type with no sign of inflammation and little phagocytosis. Sub pleural hemorrhages are frequently obsBrved.

LABORATORY
Blood examlnation is, of course, extremely neccessary both in the diagnosis of the condition and in

-18fol.lowing the results of therapy. Blood counts should
be made at the same hour every day for comparable results and preferabll_\ twice or three timr:;s per day.
This takes cognizance of the leukoC)'te tides whi:!h
occur daily.
The most outstanding laboratory finding is the
leukopenia. In a severe case' the total white cells may
be so low as to be uncountable. In practir::ally e.11 cases
the white count is below 2,000 and in some cases has
been reported as low as 200. It may be necessary to
use a I:IO dilution of the blood rather than the usual
1:20.
The second most striking finding from a laboratory
standpoint is the neutropenia. The morphology of the
· neutrophilic granulocytes is normal. There are no atypical cells, but their number is depleted to around
30 or 40

% in

the chronic and less severe cases and

there may be a complete absence in the fulminating
cases.
Krumbhaar (48) recognized a terminal rise in the
number of immature granulocytes in fatal cases

o~

mus-

tard gas poisoning. He labelled it "myelocytic crisis".
Schilling (82) called this a "degenerative shift" and
explained it on a disbalance between maturation and
chemotactic factors. The supply of maturation factor
having been depleted, the normally functioning chemotactic factor delivers immature myelocytes to the
peripheral blood. This does not mean necessarily that
the patient is recovering. It may be just an "agonal
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outpouring" of

thr~

last of the young cells.

Eosinophiles may be either absent, present irt
normal quantities or in excess of the normal quantity. The same is true of basophiles.
The lymphocytes are, in most cases, greatly reduced. Their morphology rema.ins perfectly normal.
The mechanism of their reduction is obscure as there is
no evidence of destruction of lymphoid tissue.
Monocytes and transitional cells become reduced
in number as the disease becomes more sevr:;re. Their
morphology remains normal. Ferrata (22) theorized that
the macrophage cells of the reticulo-endothelial system might acquire granules and take over the work of
the granulocytes in the emergency. He found such cells
in the blood stream, containing

eith~r

basophilic

o~

eosinophilic granulations and termed them "hemohistiocytes".
If the disease lasts more than the usus.l ten days
there may be a diminution of erythrocytes. In fulminating cases the erythrocytes are not affected because
there is not time. When anemia is present it is usually
of

the:~

secondary type with hypochromia.

In malignant granulocytopenia due to benzene or
other drugs the blood platelets are reduced. In other
forms of the disease they remain normal unless the bone
marrow becomes aplc:..stic.

-20-

Rutledge and hL; assoclates (78) found that
during an attack the motility and viability of the
granulocytes was much reduced, and their capacity to
take the neutral red dye diminished.

~he

motility

never approached normal and their average length of
life was only one-half normal.
Roberts and Kracke performed. the following experiments to determine the toxicity of the serum.
Vllhen their patient'$ white count totalled 400, they
took 2 c·.c. of the patient's blood (ox&.lated) and
mixed it with 2 c.c. of normal blood of the same type.
A normal control was set up •. Differential

an~

total

white counts were made at two hour interv<:1.ls for 48

hours but neutrophilic destruction could not be demonstrated. Other experiments have had similar results
and one may say that sufficient proof is not at hand
regarding the toxicity of serum in granulocytopenia.
Biopsy on the sternal ms.rrow is the best

mr:~thod

for differentiation between granulocytopenia with
a maturation arrest and granulocytop8nia with myeloid
aplasia; and in aiding the differential diagnosis
versus other bone marrow dise<:ses. Biopsy on the fresh
specimen of bone marrow is far superior to the specimen observed at autopsy.
The urine in granulocytopenia is not significant
and the findings are those of any other febrile disease.
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Many

ca~'>es

have a negative blood culture. 1r,:nen

positive the organisms most frequently found are the
streptococcus viridans and hemolyticus, the staphylococ·::us aureus, pneumococcus, colon bacillus and the
bacillus pyocyaneus.
Cultures from the mouth and throat reveal the
normal inhabitants of th!is area,

Vincent'~'

s pirillurn,

the fusiform bacillus, pneumococci, s treptoco'.::ci and
staphylococci. Their abundance is in direct ratio to
the decline of granulocytes.

SYMPTOMS AND CLINICAL COURSE
There are two clinical types of the syndrome
recognized, the acute, and the chronic

o~

recurrent.

In the former the onset is abrupt with a chill, high
fever, and oftentimes a necrotizing angina. There may
be extreme prostration, hd<.idache, vomiting, muscle
pains and delerium suggesting sepsis . .Jaundice and
albuminuria are present in a certain pereentage of
cases. The blood shows an extreme degree of 1eukopenia
and neutropenia. The ulceration and necrosis re:>embles
diptheria and may t.nvol ve tonsils, pharynx, gums, tongue,
larynx, esophagus and more rarely the skin, rectum,
vulva, vagina or perineum. These ulcers are non-marginated with overhanging edges and a complete absence
of surrounding inflammatory zone. The lymph nodes of
the neck are usually enlarged and the liver and spleen
may or may not be palpable. Petechiae have been desc-
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ribed Jn a few instances. The urine may show casts
and bile. Signs of bronchopneumonia are pror1e to develop in the terminal stages of the

dise~se.

The chronic, recurrent form of:' the dis0ase may
be rel&tively mild with symptoms of exhaµstion or of
a low grade infection. Patients with this typi:; may
have sevf..:r::;.l attacks with weeks or mon+,hs e1a.psing
in between. This condition, with slight remissions,
may persist for ye<::t.rs or the p&tif'.mt m::.y succumb
during an acute exacerbation.
The presence of an ulcerative or exudative.
lesion in the throat or mouth should always suggest
the necessity for a blood examination as well as a
culture. The neutropenia precedes all symptoms according to the bulk of the

liter~ture

on the

subj~ct.

·

To wait for the appearance of sore throat, fever and
angina is merely giving the army of orgRnisms a chance
to invade the tissues.
A·:typical history is the appearance of sore throat
in a middle aged, usually debilitated individual, accompanied by chills and fever, ulceration and then membrane formation in the throat and on the buccal

mur~ous

membrane. If angina is absent, and few cli-nical signs
are present, the diagnosis is far more difficult.
A total leukocyte and differential count should
precede the

r~xtraction

of teeth and tonsillectomy.

If angina and fever are both absent and there are only
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weakness, malc..ise

c:~nd

dro vs iness, a frequent leukoc::yte
1

and diff8rential count should be made. Some authors state
that normal numrers of circulating erythrocytes and thrombocytes are

essen~ial

to the diagnosis and do not ac2ept as

granulocytopenia any case in which there is an ahsolute
decrease in lymphocytes or endothelial· leukocytes.
A sternal marrow biopsy wou!d aid in the diagnosis

and in distinguishing the aplastic from the hyperplastic
type. Plum (68) hc.s studied the bone mc-.rrow by

pun~ture

at various stages of the disease and states that the
prodromal marrow shows a depression of immature granulocytes with normal mature cPlls. The fully developed
condition is marked by absence of granulocytes and
increase of myeloblusts. The beginning of regeneration
is manifested by incipieµt production of granulocytes,
increase in myeloblasts and 'pre-myelocytes but no adult
granulocytes.

DIFFERENTIAL
Acute, follicular tonsillitis, Vincent's angina
and

dipth~ria

are to be differentiated by routine leuk-

ocyte and differential counts and appropriate clinical
means. None of the afore-mentioned causes a leukopenia.
Patients with streptococcic sore throat with
streptococcus hemolyticus septicemia usually have leukopenia but sP-ldom less than 4,000 cells and the differential count usually shows at least 85

%neutrophiles.

In typhoid C<ises and in influenza the leukocyte count is
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rarely less than 4,000 and the neutrophilic percentage is at least 25. Generalized, rapidly advancing
tuberculosis may show a marked, progressive leukopenia, as low a.s 3,000 cells, but the neutrophiles
comprise from 90 to fi9

%,

mostly immature forrr::s.

Pneumonia may at times cause leukopenia, rarely
below 6,000 cells and there is always a preponderance
of neutrophiles.
The condition known as lympho-sarcoma mfay cause
leukopenia with a reduction in neutrophiles. Biopsy
findings from the enlarged lymph glands vdll make this
differentiation clear.
Aleukemic leukemia is characterized by an anemia
and usually a thrombocytopenia. The anemia is marked,
progressive and of a macrocytic type. In granulocytopenia, anemia is rare and of a rnicrocytic type. In leukemia, blast forms appear eventually although they may
not be present at the onset. Nucleated red cells are
found and considerable bleeding from the gums occurs.
The disease lasts a longer time than granulocytopenia.
In acute leukemia there is a very high cell count
and there are large numbers of immature cells with the
stem cells predominant. Acute leukemia is common in
childhood and patients with a temperature of !02-4 degrees seem comparatively well. In granulocytopenia there
is a very low cell count and very few stem cells and
other young forms are present. Over 20

%of

stem cells

usually means leukemia. The syndrome of granulocytopenia
is rare in childhood and temperatures of 102-4 degrees
usually mec;n prostration. In lymphatic reaction!"'·

-25-

there is an absolute increase in lymphocytes 'Which
replace the neutrophiles to make the total leukocyte
count normal or increased.

Th<~re

are usually many

abnormal lymphoid cells, while in granulocytopenia the
lymphoid cells are normal. Even so, the differential
diagnosis is so difficult as to be well nigh impossible.
The bone marrow biopsy will establish the diagnosis
in doubtful cases. In the leukemias there is a c:::rowding
of the marrow with lymphoid cells.
Aplasia

of the bone marrow (aplastic anemia) has

anemia, thrombocytopenia and usually hemorrhagic pneumonia present. The disease is protracted and the bone
marrow will often show a depletion of all jts elements.
There are sub-cutaneous hemorrhages from mueus membranes
and other parts of the body. There is aplasia of the
bone marrow as a whole. The yellow marrow is devoid of
erythrocytes, leukocytes and megakaryocytes. There are
leukopenia, neutropenia, thrombocytopenia and rapidly
advam::ing hyperchromic anemia. Thr:;re is a. re la ti ve increase in lymphocytes and the; color index is irrP15ular.
If anemia is present it is of the secondary type and the
erythrocytes are more or less achromic.
Infectious mononucleosis usually occurs in young
adults, often in their early twenties. Lymphadenopathy
is often generalized, the spleen is palpable in many
cases, leukocytosis is common, and the lymphocytes may
show fenestration or vacuolization of their nuclei.
The absolute.number of neutrophiles is usually not re-
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duced and many of them are immature. The injection of
foreign protein will result in an increase in the nurr:her
of circulating neutrophiles. The clinical manifestations
are usually much less severe than in granulocytopenia.
Care must be taken also to differentiate pernicious
anemia in an aplastic phase and metastasis to the bones
from neoplastic processes.

TREATMENT
All schools of thought agree that the primary
step in therapy is to find the causs of injury to the
bone marrow, if such cause can be isolated, and to remove it. History of the use of amidopyrine, dini troph(mol,
gold salts, arsenicals, and numr:rous proprietary remedies should be especially sought for.
A review of the literature would suggest that most

authors believe that a specific agent in therapy has
not been found. The fact that some cases show spontaneous remission would make this rather hard to check.
N(~ver-the-less,

there are numerous measures advocated.

and each has its enthusiastic supporters.
Friedemann (28), in 1927, advocated "stimulating"
doses of x-rays. He applied one-tvrentieth of an erythema
dose of roentgen rays to the bones of the skeleton giving from one to two treatments at intervals of from two
to several days. He reported that improvement from this
th·::rapy may begin within from 24 to 48 hours, both as to
clinical and blood picture. In the adult, the marrow in
the long bones is mainly adipose tissue having little or
no blood forming function. When pathologic demand exists
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there is a formation of new centers by differentiation
. of the myeloblasts into gr<mular myelocytes, the adipose
tissue of the bone marrow being replaced by this newly
formed tissue .• One theory is that it aids in the formation
of this new tissue. There is no evidence, however, that
a cell is affected in any but a destructive way by the
roentgen ray.
Dean's theory is that x-rays benefit those cases
having a hyperplcistic myeloid tissue. The rays bring
about a destruction of this tissue with a liberation of
autogenous nucleotide, which then initiates the maturation and delivery of granulocytes from the remo.ining
myeloid foci.
It is definitely known, however, that the x-ray
will bring about a reduction in the actual numbers of
white c_ells of both granulocytic and l;/mphocytic patterns
and the consensus of opinion seems to be that it might
be a distinctly dangerous proceedure by causing further
bone.marrow depletion.
_The nucleic acid derivatives offer the most hope

along the line of specific theraps-utic measures. Reznikoff (7I) introduced the use of intravenous adenine
sulfate on the assumption that nucleic acid derivatives
stimulate polymorphonuclear production. This is given
in one gram doses, dissolved in

~O

c.c. of saline brought

to a boil. It is given as warm as the patient can stand
as it goes out of solution 8asily. Thrombosis may occur
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if some enters

th~

wall of a vein and if it enters

the surrounding tissues, nc3cros1s and even sloughing.
may occur. Three doses for three days is usually adequate if the drug is effective.
In

193~~,

Jackson, Parker and Taylor (2:i4) introduced

pentnucleotide. They advocated the injection of IO c.c.
intra-musculb.r ly four times a day if possible.

~~rr.a.11

doses of I c .c. are increased hourly until th<:: above
quantity is being given. An unpleasant reaction manifests itself by a sense .of c·::nstriction in the chest,
pounding in the head and general distress.
Jackson (36) was the first to demonstrate that
pentose nucleotide existed in normal human blood. It
is known to exist principally in the nuclei of living
cells. Doan and his co-workers showed that granulocytes
could be called from the marrow by the split products
of nucleic acid, adenine and guanine, and there was no
transitory leukopenia due to splenic storage. These
substances, given intravenously to rabbits, caused a
marked increase in the number of circulating granulocytes without affecting the other cells.
Doan, experimenting on normal rabbits with pentose nucleotide, produced not only an extensive degree
of myeloid hyperplasia, but also an extra medullary
myelopoiesis in the kidneys and spleen.
The nucleoproteins of the body exist as combinations of nucleic acid with protein material. The acid

is found within the ce:ill in free form in cases. The
amount and character of the protein with which the free
acid combines is variable. Those tissues which contain
the largest amount of nuclear material are richest in
nucleic acid. This includes such tissues as thymus,
spleen, liver and hematopoietic tissue. Nucleic acids
on hydrolysis yield the purine and pyrimidine nucleotides.
The purine nucleotides on hydrolysis yield the purine
bases, adenine and guanine.
Jackson and associates (35) in their series of
cases used the unbroken pentose nucleotide K-96 under
the direction of Harvard Medical School. Twenty patients
were treated. Of the thirteen whose condition could be
classed as malignant, seven recovered. The first sign of
improvement occured on the fifth day usually. The consistency of this they compared with the Teticuloctte
raise which occurs in pernicious anemia following liver
therapy. Jackson and his workers concluded: "We believe
that these nucleotides may have a definitely favorable
effect on the very active bone marrow and in certain
cases we believe the substance well worth trial."
Gordon (29) has classified the types of treatment
which have been employed in granulocytopenia;

A. Blood - intravenous, intramuscular and intraperitoneally -

both·h~~althy

and that from a recovered

case.
P. Biological - nucleinic acid, nucleotide, leukocytic cream, bone marrow, sterile milk and foreign
proteins.
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c.

Bacteriological - typhoid vaccine,

~acterio

phage and bacterial serums.
D. Glandular - mainly from the liver, fetal spleen,
thyroid and adrPnals.

E. Physical - x-rays, radium and sterile abscesses.
F. Chemical - adenine sulfate, purine base, calcium

sulfate, arsphenamine.

G. General - allied stimulation, intravenous glucose,
intravenous saline, diet and locally mouth washes, irrigations, oral hygiene.
Gordon's successful treatment is as follows:

I. A high nuclein diet.
2. General therapy as mentioned above.
3. Small blood transfusions - (contra-indicated

where there are signs of liver exhaustion such as jaundice
as an increased strain on the liver will cause blood to
be broken down.)
4. 40 c.c. of whole blood intramuscularly twice a

day.
5. Nucleotide and nucleinic acid.
We have seen that diet may play a very important role
in the etiology of theis condition. If this be true, it
should follow that it might also prove important in therapy. Doan was able to reduce the red marrow of the radius of pidgeons to an extreme hypoplasia by underfeeding.
The work of Miller and Hhoades (59) in the production of acute stomatitis with neutropenia and granulocytopenia in dogs by means of a black tongue diet would
strongly suggest that a diet rich in vitamin B should be
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of material aid.
In granulocytopenia due to arsphenamine very good
results have been h.::.i.d. from the intravenous u;;e of sodium thiosulfate. This can also be given by mouth. i'vlc bride and Dennie suggested that it be given in not more
than 20 c.c. of distilled water, with daily intravenous
injections for four days, and then on alternate days,
for as many injections as may be neccessary, in doses
starting with • 3 gram and increasing by • I5 gram da'ily.
This drug is non-toxic in quantities up to 2 grams.
The prodromal signs of toxicity are itching and a mild
rash, prolonged fever and a tendency toward purpura ..
Spleenectomy has been advocated in this condition
and has been tried. It is generally conceeded, however,
that the proceedure is poorly suited to the form of
pathology present in these cases.
Tr<:tnsfu':lions have been used in many of the cases
reported, some recovering and some dying. Heports, on
the whole,, have been satisfactory al though the

proc(~edure

is essentially emperical. There is no evidence that
transfusions stimulate the neutrophilic development,
and the number of neutrophi.les added in 5CO c. c. of
blood would be of little assistance, particularly as
the life of a neutrophile is short (5 days). Th0re is
a possibility that blood from a healthy donor

mi~ht

have the principles to bring about normal maturation
but here again it is highly conjectural and the amount
woulq be small.
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Reznikoff (7I) feels that fatigue is a definite
factor in the production of th,,, syndrome. He reasons
that treatment should include absolute re':;t and fr8edom from worry as far as

pos~ible.

The chronic cases

in particular improve with rest.
Reznikoff has a theory regarding the action of
liver, quite actively used in therapy. He states that
the myeloid elements of the bon; marrow are in close
contiguity with the hyperplastic, erythroblastic tissue
and may be influenced by changes in the latter. With
response to liver therapy the leukocytes usually increase (in.pernicious anemia anyway) and with this in
view mcny workers have been giving intravenous liver
extrac~

for acute granulocytopenia. Many favorable

reports have been given.
Miscellaneous agents which have been given include turpentine to produce a local abscess, intramuscular injections of milk, intravenous injections
of gentian violet and acriflavine; all have been used
to stimulate the production of granulocytes, but to
no avail. Leukocytic cream, typhoid vaccine, bacteriophage and bacterial serums have all been used. Glandular extracts include those from thyroid, adrenals,
spleen, liver. Other recommended measures have been
elsewhere mentioned.
General measures include treatment of th8 oral
lesions. Sodium perborate gargles followed by swabbing
of the ulcers with a two percent solution of copper
sulfate should be used five times per day.

Foci of infection should be cleare8 up with
P'' rticuhjr referencE: to the oral cavity. :clJrgery
should be undertaken if absolutely neccessnry.

Abscesses should he localized and drained just as
with a norme;l blood connt.

"P" complex

A diet rich in vitamin

s~ems

~o

have value, especihlly jn the chronic cases.
Fluids should be forced.
rrc~commencl

~ome

autho~ities

giving as high as five or six luarts per

day.
It might be well to m8ntion herR one recent

and 1.,•:atkins of the 1h:iyo clinic with good results.
This is extract of yellow bone marrow. The dosage
r;i}1
·:
, ,t L.1

type of therapy is said to
~A

to 1-8 hours, whereas

produ~e

'

o..'

a response in

pentn11r~l00'.~.ide

therapy tc-J.kes

from four to five days. This bone marrow is given
orally and does not produc:e the ;evere, painful
reactions of pentnuclGotide.
While no one therapr,iutic mea:::;ure me:;.y be hailed

as specific, th'; enthusiastic end or ;i:;mc;:,nt ::;i vc;n a few
of the ahove n-i;mtioned me <n.rres would

~-::ert;ain.ly

c:eerr:

to m Ti t their further s t-,udy.
0

TH?

n~1ATIONsn1p

TO THS

SUL~o~~VIDE

Since the middle of the
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~Eedici11e

ht~.s

o~ GRhNDLOCYT1PB~IA
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therapy, enthusiasm has centered around one group
of drugs; those of the sulfonamide series. Variously
known as the "magic drugs", and the "wonder drngs",
their use has become universal and their efficacy
proven for all time. Unfortunately, .they are·not
V'li thout their dangers, dangers bound to be magnified

through the promiscuous use - and misuse which always
follows in the wake of such a discovery. One of the
graver complications of the use of these drugs is
the development of granulocytopenia. The complication
is particularly sinister in that the toxic effects may
occur days after cessation of the drug, and relatively
few clinical manifestat:i.ons occur until the syndrome
is definitely established. Reznikoff (7I) predicts
that ~he sulfonamide derivatives will replace amidopyrine
as the number one cause of granulocytopenia.
To illustrate the type of granulocytopenic syndrome which follo•.·\'s on the heels of sulfonamide therapy, its method tf induction, time of onset, outcome,
and some

therap~t1tic

measures which ha·ve been used to combat

it; I have deemed it wise to select at random some
case histories from the current literature. Many of
these have points in common, but in

gen·~ral

thf:.>re are

enough variable features that one hesitates to predict
the action of the drug in any given .3et of circumstances.
This unpredictability remaJ.ns the g:rea t mystery of
granulocytopenia. 'Nhy the sulfonamide drugs should aid
the white cells in one person and depl8te them in another
is beyond the scope of our present knowledge.
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Schwartz, Garwin and Koletsky (83) report a
case of fatal granulocytopenia following sulfanilamide therapy. The case, a chronic, penile ulcer.
The treatment consisted of 5 grams of sulfanilamide for two days, then two grams daily for
three days. A routine blood colint at this time
showed total leukocytes to be in the neighborhood
of 2,000. The drug was stopped at the end of 2I
days when the patient had received a total of 56.6
grams. Four days later the patient was icteric with
the liver well below the costal margin. There was
slight necrotic ulceration in the tonsillar region.
Dea th occurred on the following day. The nec:!ropsy
included a myeloid series of th•; bone marrow which
showed maturation arrest with s'tem 'cell hyperplasia
and complete absence of more mature cells.
Berg and Holtzmann (5) report the case of a
man, age 22, in excellent health, who

rec~ived

sulf-

anilamide th.,:rapy for gonorrhea.
Five grains ware given every four hours for five
days at which time the patient developed slight fever,
cramps and nauJea. The sulfanilamide was stopped altogether, to be started four days later. After ingestion
of a total of 38 grams he had a chill, fever, uncontrollable vomiting and abdominal pain. The diastolic blood
pressure was 50, pulse 130, temperature I07 degrees. A
blood count revealed a total absence of polymorphonuclear
cells. Death occurred in spite of pentnucleotide therapy.
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F.D. Johnston (40) r?ported a case in a woman,
age 23, who was treated for a pw:rperal infection due
to the hemolytic streptococcus, group A. 6I.3 grams of
prontosil was given both orally and intravenously over
a 20 day period. A blood count at this time showed a
total white count of I500 with no granulocytes and a
severe secondary anemia. Thi"!rapy for the granulocytopenia
consisted of a drip transfusion of defibrinated blood
given over a 28 hour period. Pentnucleotide injections
were given twice daily for 5 days (.35 g.). The patient was well two weeks later with a. white count of
7550 - normal differential •
.Johnson also reported a case which followed the
treatment of acute pemphigus with M. and B. 693.
The patient, a male age 29, was admitted to the
hospital in profound toxemia with a temperature of
I03 degrees, pulse of II6, respirations 20. There were
inch wide lesions covering the entire body. These
lesions were bullae filled with clear fluid. The response to M. and B. 693 was dramatic after only

~-58

grams of the drug had been given, but the patient had
a white count of 6000, with only I? rf polymorphs., of
which 90 % were immature. Pentnucleotide

thE~rapy

was

started and the blood pict 1re rapidly became normal.
1

Sakula reports (BI) the treatment of a case of
meningitis due to the Pfeiffer bacillus with M. and
693, which was complicated by granulocytopenia.
The patient, age 2-l years, was admitted to the

~.
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hospital with a temperature of 103 degrees, pulse 128,
respirations 48. Neurological signs were positive for
meningitis. Culture of the spinal fluid proved Hemophilus Influenzae. 2.5 grams of M and B 693 were given
per day. When I7 grams had been given the drug was
stopped, due to a generalized rubella rash all ovP-r
trunk and limbs. The white count was 23, 000

·~ri th

79

%

neutrophiles. By the next day the rash was gone. Five
days later the temperature and pulse, wh.ich had been
normal, ro;::;.e again and the drug was again given in
doses of 2 grams per day for 5 days. At the end of the
five days the leukocyte count had .fall.en to 2,IOO with
5

% neutrophil~~s. Pentnucleotide was given for 9 days

at the encl of which time the white count was I5,500
with 58

% granulocytes.

J.G.G. Borst has reported (8) a case of death
resulting from an a.granulocytic complication of treatment with prontosil flavum.
The patient, age SI, was admitted to the hospital
with a temperature of I02 degrees, white count of 8,000
with 5I

~

polymorphs. The diagnosis was pyelocystitis.

For ten days she received 6 tablets per day of prontostl
flavum (300 mg. per tablet). Her symptoms disappeared,
the tempc::rature dropped and the urine bec<:J.me pus and
bacillus free. prontosil was stopped and the pyelocystitis returned. Prontosil was resumed at the same
dosage for

~~O

more days . .A routine white count at this t'tne.

-38-

showed a total of 1225 with

2i %polymorphs.

Two

days later the patient's throat was red, swallowing
was difficult and death ensued. The white count at the
time of death was 960 with I

%polymorphs.,

87

oJ

lymph-

ocytes and I2 % monocytes. (Prontosil flavurn is usually
given to patients suffering from acute streptococcal
sepsis and where the illness is already severe, slight
symptoms of intoxication are not recognized easily so
that not even a serious complication like granulocytopenia
will alter the picture radically enough to attract
attention. The importance of routine blood counts is
again emphasized.)
Jennings and Southwell-Sander report (39) a case
developing in a housewife, age 39, with a diagnosis of
ulcerative colitis with stool culture positive for
dysentery bacilli.
Sulfanilamide, four grams per day, was given for
three weeks. The infection disappeared and the patient
was discharged as well. Five days after quitting the dr0g,
there was a temperature of I03.5 degrees. The pharynx
wa::> reddened with a white exudate. The total 'Nhi te
count was 444 with

a complete

absence of granulocytes.

The treatment consisted of pentnucleotide, .7 gram intramuscularly twice a day for 3 days then once per day for
2 days. The temperature became normal in 2 days. The
white count returned to normal in one week.
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Long, Haviland, Edwards and Bliss (56) have
given an excellent analysis of the toxic manifestations of sulfanilamide and its derivatives. They have
analyzed the incidence and types of toxic reactions
occuring in

ho~Jpitalized

results, l,000 of whom were

treated with sulfanilamide, 297 with sulfapyridine
and 29I with sulfathiazole in Johns Hopkin's hospital
over a period of years.
They conclude that leukopenia with granulopenia
may occur early or late in the course of therapy with
sulfanilamide or its derivatives. They have noted a
sharp drop in total leukocytes in certain cases following a single dose, in other cases not showing up until
60 or 70 days after treatment. No deaths have been
reported from disturbances of the white cells during the
first I2 days of therapy.
They state further that acute granulocytopenia is
a rare occurence and the most common time of appearance
is from the I7th to the 25th day. Hence the blood count
should be checked daily from the 12th day on. Stop the
drug and vigorously force fluids in any decrease of
total white ce1ls and polymorphs _. The forcing . of fluids
helps to rid the body oft.he drug. Transfusions are t8
be used when the hemoglobin value fall's below 70

%.

The prognosis is good when the toxic reaction is recognized in its inception.
At the time of visit to one of these patients, the
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physician should inquire as to his symptoms especially in respect to headache, body aching and
malaise. These are often the precursors of ms.ny of
the toxic reactions to sulfanilamide or its derivatives. The sclera should be examined for jaundice,
the mucus membranes for pallor and the skin for evidences of rash. The temperature should always be taken
in order to det,;ct whether drug fever is present.
Lastly, one should remember that if a patient
has once had a toxic reaction with one of these drugs,
the next time the therapy is instituted he is likely to
have an earlier and more severe reaction. Patients having a toxic reaction to one of these drugs may have a
similar reaction when another of the group is prescribed.
The following table shows the incidence of granulocytopenia which they found in this series.
SULFANILAMIDE
SULFAPYRIDINE
in .I %of cases;
in .3 % of cases;
occurs on I4th to
I4th to 40th day,
40th day, more freI7th to ~5th mostly.
quent on 17th to 25th.

SULFATHIAZOLE
not reported
but may occur.

PROGNOSIS
The prognosis in grmulocytopenia is always grave,
the mortality being at least 75

~.

The outlook appears

to be more serious with severe grades of leukopenia and
complete absence of polymorphonuclear cells from the
blood, though even these cases may recover. Total monocytes numbering IOO to 200 are believed to be of favor-
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able import. The appearance of eosinophiles, a progressive rise in the white count and in the number of
granulocytes are good omens. In general

th~

outlook

will depend upon the kind and degree of bone marrow
injury, the degree of secondary infection

a~d

the gen-

eral recuperative power of the marrow.
SUMMARY

l. Granulocytopenia is a syndrome characterized
by an acute, febrile course, neutropenia, ulcerative
lesions of the mucus membranes, and a high mortality.
2. Although probably existing prior to 1922, we
usually date it from Schultz' observations in that year.
Our concept of the disease has changed gradually as
it has become apparent that a large number of bacterial,
toxic, chemical and physical agents can produce it.
The group of cases designated "idiopathic" is becoming
steadily smaller as more of these agents are discovered.
3. The term "agranulocytic angina", in greater
use than any other, is somewhat ambiguous, as are many
other of the suggested names. The term "granulocytopenia"
is brief, descriptive, and contains no ambiguities.
4. Perhaps the most outstandlng work in establishing the etiology of the condition was that of Kracke,
who incriminated drugs containing the benzene nucleus.
Many other drugs, not containing this radical, have been
shown to produce the syndrome; as well as bacteria, physical agents, sera and antitoxins. A congenital condition·
of the bone marrow has been demonstrated in some cases.
Allergy has been found closely associated in some cases.
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A clos1::; relationship to the menses and pregnancy has
long been noted. Dietary factors and the possibility of
a virus cause have recently been

m~ntioned

in the lit-

erature.
5. The most striking pathological finding is the
total or relative absence of white .cells of the granulocytic series in both bone marrow and the peripheral
circulation. The bone marrow at autopsy may be normal,
hypoplasic or hyperplastic. Most of the other pathology
is secondary, contingent upon the reduced leukocytic
defenses of the body.
- 6. Diagnosis of the condition is fairly easy provided frequent blood examinations are made. Leukopenia
and extreme neutropenia are the outstanding findings.
Differential diagnosis versus aleukemic leukemia and
other rare blood diseases is difficult but possible
by a strict analysis of the blood picture and the
clinical findings. The presence of an ulcerative lesion
in the mouth or throat should always suggest the necessity
for a blood examination.
The primary step in therapy.is to find the cause
of injury to the bone marrow and remove it .• No specific
has been discovered for the c ondi ti on al th01.-!gh mRny
have been suggested and tried. The most

promisin~

of

these are the nucleic.acid derivatives, adenine sulfate and bone marrow extract. Supportive measures
include frequent transfusions, removal of foci of infection and treatment of the local lesions. Due to the
tendency toward spontaneous recovery, the results of
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any therapy are difficult to evaluate.
8. Granulocytopenia can be definitely caused by
drugs of the sulphonamide series. Several case histories and the results of a series of I,588 cases upon
which records were kept at Johns Hopkins hospital are
presented to illustrate this; The extremely common
useage of these drugs make this complication an important consideration, particularly as the granulocytopenia may be latent, arising days after the drug -has
been discontinued. Blood examination should be done
frequently during the course of therapy with these
drugs. Failure to do this is almost criminal negligence.
9. The prognosis is extremely grave in granulo-

cytopenia

r"~sul ting

from any

cau:~e

V\Thatsoever. Drugs

known to cause the condition should be avoided whereever possible. Drugs in common use by the laity should
be labelled as to contents, and the public should be
instructed to avoid pain relieving or soporific drugs
about which they have no knowledge. These precautions,
accompanied by frequent and thorough blood examinations
upon the part of the physician, should do much toward
reducing the incidence of this bizarre and lethal syndrome.

****
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